Comparison of the Effects of Transdermal and Oral Rivastigmine on Cognitive Function and EEG Markers in Patients With Alzheimer’s Disease
Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2014.00179
Full Text
Open PDFAbstract
Available in full text
Date
July 23, 2014
Authors
Publisher
Frontiers Media SA